Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- Check5 days agoChange DetectedThe page shows Revision: v3.4.1 at the top, and the older Revision: v3.4.0 along with related topics like Non-alcoholic fatty liver disease and MedlinePlus Genetics were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' as related topics on the study page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study locations section was expanded to include additional sites across the United States, Canada, and Australia, and several specific location entries were removed.SummaryDifference1.0%

- Check55 days agoChange DetectedNon-alcoholic fatty liver disease and MedlinePlus Genetics were added under related topics. These changes provide supplementary metadata for discovery and indexing rather than modifying study content or patient-facing details.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved the related topic labels 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.